Cégbemutató
Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The Company is committed to having a positive impact on patients’ lives by delivering high-quality, safe and effective treatments designed to address debilitating retina diseases including all stages of age-related macular degeneration.
Igazgatóság & Felügyelőbizottság
| CEO |
| Glenn P. Sblendorio |
| Igazgatóság |
| David F. Carroll, Keith Westby, Pravin U. Dugel |
| Felügyelőbizottság |
| Adrienne L. Graves, Axel Bolte, Calvin Roberts, Glenn P. Sblendorio, Jane Pritchett Henderson, Mark S. Blumenkranz |
Cégadat
| Név: |
Iveric Bio Inc. |
| Cím: |
Five Penn Plaza, Suite 2372,New York, NY 10001, USA |
| Telefon: |
+1-212-845-8200 |
| Fax: |
- |
| E-mail: |
info@ivericbio.com
|
| Internet: |
https://ivericbio.com/ |
| Ipar: |
Biotechnológia |
| Szektor: |
Biotechnológia |
| Alszektor: |
Biotechnológia |
| Pénzügyi év vége: |
12. 31. |
| Közkézhányad: |
- |
| IPO dátum: |
2016. 12. 16. |
